Paper Details

  1. Home
  2. Paper Details

Causes of death and re-hospitalization in cardiogenic shock.

Author: AssmannSusan F, FarkouhMichael E, HochmanJudith S, JegerRaban V, RamanathanKrishnan, YehudaiLoran

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Early deaths (< or =30 days) in cardiogenic shock (CS) are mainly cardiac. Non-cardiac deaths are associated with signs of inflammation. Re-hospitalizations in survivors of the initial hospitalization are due to heart failure and myocardial ischemia.
Paper Details　
Original Abstract of the Article :
BACKGROUND: In cardiogenic shock, causes of death usually are cardiac. However, a systemic inflammatory response syndrome may influence outcome. METHODS: SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? (SHOCK) Trial patients (n = 302) were analyzed regarding cause of de...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/17482940601178039

データ提供：米国国立医学図書館（NLM）

Cardiogenic Shock: Navigating the Shifting Sands of Mortality and Re-hospitalization

Cardiogenic shock is a serious condition, often characterized by a treacherous journey through a desert of weakened heart function. This research, like a seasoned explorer charting the dangers of this perilous landscape, examines the causes of death and re-hospitalization in patients with cardiogenic shock. The researchers meticulously analyzed data from the SHOCK Trial, seeking to understand the factors that contribute to mortality and the likelihood of re-hospitalization in these patients.

A Challenging Terrain: Understanding Cardiogenic Shock

The study found that early deaths in cardiogenic shock are primarily cardiac-related, while non-cardiac deaths are often associated with signs of inflammation. Survivors of the initial hospitalization are at a significant risk of re-hospitalization, mainly due to heart failure and myocardial ischemia. It's like navigating a desert with unpredictable sandstorms, requiring a careful understanding of the terrain and potential hazards.

Navigating the Desert of Cardiogenic Shock: A Multifaceted Approach

This research provides valuable insights into the complex nature of cardiogenic shock, emphasizing the need for a multifaceted approach to management. The study's findings highlight the importance of early intervention, aggressive treatment, and comprehensive follow-up care to reduce mortality and re-hospitalization rates. It's a reminder that in the vast desert of cardiovascular disease, we must remain vigilant to improve patient outcomes and navigate the shifting sands of this challenging condition.

Dr. Camel's Conclusion

This research provides valuable insights into the causes of death and re-hospitalization in patients with cardiogenic shock. The study's findings emphasize the need for a multifaceted approach to management, including early intervention, aggressive treatment, and comprehensive follow-up care. It's a reminder that in the vast desert of cardiovascular disease, we must continue to explore innovative approaches to improve patient outcomes and navigate the shifting sands of this challenging condition.

Date :
  1. Date Completed 2007-06-13
  2. Date Revised 2014-07-29
Further Info :

Pubmed ID

17453536

DOI: Digital Object Identifier

10.1080/17482940601178039

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.